Juniper Biologics acquires cell-mediated gene therapy for treatment of knee osteoarthritis
The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa